Invasix, Inc.

For over a decade, the leaders and scientists behind InMode have been working hard to revolutionize the medical aesthetic industry, starting with its launch as Invasix in 2008. Global CEO Moshe Mizhary and one of the founding fathers of IPL technology and master physicist CTO Michael Kriendel, together delivered their promise by introducing state-of-the-art light, RF and laser solutions. In 2011, InMode received more than 10 U.S FDA clearances for their innovative minimally invasive and non-invasive technologies including RFAL (Radiofrequency Assisted Lipolysis) and IPL-based solutions. By 2016, the minimally-invasive BodyTite technology for lipolysis and three-dimensional contraction of the dermis was FDA cleared.  This year, InMode is pleased to launch the newest addition to their legacy of industry leading technology advancements: Votiva; a safe, gentle and effective non-invasive solution for feminine health.

While continuing to lead the industry with its ground-breaking innovations, InMode looks forward to contributing to the future of revolutionized aesthetic solutions across North America, Latin America, Asia and Europe.